Despite advances in anticoagulant therapies, bleeding remains a critical concern.Traditionally, the definition of major ...

That study is comparing the two drugs in patients who have already ... evaluating other indications in patients in need of antithrombotic treatment,” said Dr Christian Rommel, Bayer’s R ...

During our broad discussion, Professor Kakkar provides a review of where the treatment of both venous and arterial thrombosis currently stands and the most innovative new drug interventions to ...

Among the other 3684 patients who had no history of myocardial infarction or stroke, 366 would appropriately have been given prophylactic antithrombotic drug treatment because they were older than 50 ...

Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, ...

The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...

The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...

Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.

Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

For decades microtubule-targeting agents (MTAs) have been a cornerstone of cancer treatment regimens and continue to be heavily employed as backbone chemotherapy in combination with new targeted ...

A new clot-busting drug for stroke works as well as a decades-old drug Patients given tenecteplase had similar outcomes to ...